Heavy investments across the entire bioproduction value chain – from R&D to industrialization and the relocation of production – are behind the growing boom in biotechnology in Europe, to gain competitiveness and catch up with other regions such as the United States.
In this context, optimizing the control of bioproduction processes and the environmental monitoring of the biopharmaceutical industry is key to supporting the competitiveness of companies and no longer making quality control a bottleneck in the value chain of bioproduction but rather a real added value. Download this document to learn more.
Bridging the gap between standard processes and automation, 3P® ENTERPRISE revolutionizes the future of EM. From sampling to trending, keep control with an end-to-end fully digitalized and automated workflow, increase your efficiency and ensure your products are safe and compliant.
Cybersecurity is integrated in the design of our products. Supported by our partners and bioMérieux experts in cybersecurity and data privacy, bioMérieux has implemented a Secure Development Lifecycle that ensures Security by Design and follow the highest cybersecurity standard ISO/IEC 27002.
Learn more about 3P here
Sponsored By :
